TrialTrial of AD113 and Atomoxetine in OSA Patients With Hypertension
Trial details
- Registry ID
- NCT04905979
- Phase
- Phase 2
Drug research
Atomoxetine
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Trial of AD113 and Atomoxetine in OSA Patients With HypertensionNCT04905979 | Apnimed | Phase 2 | Completed | 2023-01-31Actual |
| Crossover Trial of AD036 in Obstructive Sleep ApneaNCT04445688 | Apnimed | Phase 2 | Completed | 2020-12-01Actual |
Crossover Trial of AD036 in Obstructive Sleep Apnea
Trial details
- Registry ID
- NCT04445688
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |